Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Health Psychol. 2022 Jul 28;41(11):864–873. doi: 10.1037/hea0001190

Figure 3.

Figure 3.

A) Depressive symptoms increased from pre- to post-treatment at each cycle, and pre-treatment depressive symptoms increased with each successive treatment cycle. B) The proportion of participants reporting clinically meaningful depressive symptoms (HADS ≥8) did not change within or across treatment cycles.